Cargando…
Two-Year Outcomes of Treatment-Experienced Adults After Programmatic Transitioning to Dolutegravir: Longitudinal Data From the VICONEL Human Immunodeficiency Virus Cohort in Lesotho
In the Viral Load Cohort North-East Lesotho (VICONEL) human immunodeficiency virus cohort, 14 242 adults had transitioned from efavirenz- or nevirapine-based antiretroviral therapy (ART) to dolutegravir-based ART by October 2021. Rates of viral suppression to <50 copies/mL were 84.8%, 93.9%, and...
Autores principales: | Tschumi, Nadine, Lerotholi, Malebanye, Motaboli, Lipontso, Mokete, Moliehi, Labhardt, Niklaus D, Brown, Jennifer A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640687/ https://www.ncbi.nlm.nih.gov/pubmed/37358226 http://dx.doi.org/10.1093/cid/ciad390 |
Ejemplares similares
-
eHealth supported multi-months dispensing of antiretroviral therapy: a mixed-methods preference assessment in rural Lesotho
por: Scherrer, Ramona, et al.
Publicado: (2022) -
The viral load monitoring cascade in a resource-limited setting: A
prospective multicentre cohort study after introduction of routine viral load
monitoring in rural Lesotho
por: Glass, Tracy Renee, et al.
Publicado: (2019) -
Assessment of a viral load result-triggered automated differentiated service delivery model for people taking ART in Lesotho (the VITAL study): Study protocol of a cluster-randomized trial
por: Tschumi, Nadine, et al.
Publicado: (2022) -
Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor‐ to dolutegravir‐based antiretroviral therapy: A prospective cohort study in Lesotho (DO‐REAL study)
por: Brown, Jennifer A., et al.
Publicado: (2021) -
Policy and programmatic directions for the Lesotho tuberculosis programme: Findings of the national tuberculosis prevalence survey, 2019
por: Matji, R., et al.
Publicado: (2023)